⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANTX News
AN2 Therapeutics, Inc. Common Stock
AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
businesswire.com
ANTX
AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer
businesswire.com
ANTX
Form 8-K
sec.gov
ANTX
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of AN2 Therapeutics, Inc. (NASDAQ: ANTX)
prnewswire.com
ANTX
Dye-Free and Label-Free Packaging for PCR Optimization Market Insights Just Released — Breaks Down Market into Sustainable and Automated PCR Packaging Solutions
globenewswire.com
TMO
BIO
ANTX
Form 8-K
sec.gov
ANTX
Form 8-K
sec.gov
ANTX
AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease
businesswire.com
ANTX
AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
businesswire.com
ANTX
Form 8-K
sec.gov
ANTX